PATENT CLAIM ANALYSIS

Application Number: 15757189
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "649000"]

Abstract:
The present disclosure provides a method of treating a patient with refractory or resistant cancer by administering a therapeutically effective amount of a compound of formula (I), such as Varlitinib, or an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same. Also provided is a compound of formula (I) for use in the treatment of resistant or refractory cancer and use of a compound of formula (I) for the manufacture of a medicament for the treatment of resistant or refractory cancer.

Claim (Index 1):
A method of treating a human patient with refractory or resistant cancer by administering a therapeutically effective amount of a compound of formula (I): an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same, wherein each dose of the compound of formula (I) is in the range 100 to 900 mg, and wherein each dose is administered once or twice daily.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.93878
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757133', '13641557', '12586849', '11470331', '14247799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6570663710799124
- 35 USC 102 Novelty (BERT): 0.519800111797858
- Combined Prediction Score: 0.643339745151707
- Mean Citation Score: 167.225026
- Max Citation Score: 262.58035
- Similarity Product: 170.3834205082834

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test